Sepiapterin
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 633 publications
Cell type diversification and phenotype convergence underlying white fin-ornamentation of cyprinid fishes.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 24, 2026
Targeted endothelial GTPCH1/BH4 pathway activation reverses vascular dysfunction in smoking-associated obesity.
Journal: Biochemical pharmacology
Published: January 15, 2026
The genetics, evolution, and maintenance of a biological rock-paper-scissors game.
Journal: Science (New York, N.Y.)
Published: January 01, 2026
Sepiapterin as a treatment for people living with phenylketonuria: a plain language summary of the APHENITY trial.
Journal: Journal of comparative effectiveness research
Published: December 09, 2025
3D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells.
Journal: Journal of visualized experiments : JoVE
Published: November 03, 2025
Efficacy and safety of sepiapterin versus sapropterin in patients with phenylketonuria: Results from the Phase 3, randomized, crossover, open-label, active-controlled AMPLIPHY trial.
Journal: Metabolism: clinical and experimental
Published: October 28, 2025
No QTcF Prolongation with Sepiapterin: Results From a Thorough QT Study in Healthy Subjects at Therapeutic and Supratherapeutic Doses.
Journal: Journal of clinical pharmacology
Published: October 14, 2025
From dietary restriction to disease-targeted therapy: Sephience TM (sepiapterin) in phenylketonuria.
From dietary restriction to disease-targeted therapy: Sephience TM (sepiapterin) in phenylketonuria.
Journal: Annals of medicine and surgery (2012)
Published: September 26, 2025
Dietetic guidance for nutritional management of people with phenylketonuria receiving sepiapterin.
Journal: Molecular genetics and metabolism
Published: September 26, 2025
Endogenous tetrahydrobiopterin in humans: circadian rhythm, sex, race, age, and disease status.
Journal: Frontiers in pharmacology
Published: September 15, 2025
The dysregulation of tetrahydrobiopterin biosynthesis exacerbates the progression of chronic liver disease by modulating choline metabolism pathways and inflammatory responses.
Journal: Current medicinal chemistry
Published: August 10, 2025
Last Updated: 04/28/2026